The Inflation Reduction Act was signed into law on August 16, 2022, and the debate over its Medicare-related benefits and ...

Researchers from Bulgaria conduct an analysis of the potential for therapeutic vaccines in by comparing testing results for ...

Patients seeking free preventive care continue to face cost-sharing and administrative hurdles, a study reveals.

The FDA approved benralizumab (Fasenra) for adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).

Chairs and presenters from the 2024 World Conference on Lung Cancer comment on their favorite parts about attending this ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...

Genetic variability and sex-specific differences may play a role in sickle cell disease (SCD)-related pain; however, more ...

Though magnesium has long been seen as a potential sleep aid, the authors say the new form of magnesium salt may provide a ...

Cases of atrial arrhythmia in patients with Duchenne muscular dystrophy (DMD) are common but lack a standard solution, and ...

Medical experts highlight key data from the FRESCO-2 trial on fruquintinib for previously treated metastatic colorectal ...

Panelists discuss how type 2 inflammatory diseases, such as asthma, atopic dermatitis, and chronic rhinosinusitis, can significantly impair patients’ quality of life through persistent symptoms and ...

Medical experts compare the efficacy and safety of new therapies, including FTD/TPI plus bevacizumab and fruquintinib, to regorafenib for metastatic colorectal cancer.